Your browser doesn't support javascript.
loading
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.
Lim, Jing Quan; Huang, Dachuan; Tang, Tiffany; Tan, Daryl; Laurensia, Yurike; Peng, Rou-Jun; Wong, Esther Kam Yin; Cheah, Daryl Ming Zhe; Chia, Burton Kuan Hui; Iqbal, Jabed; Grigoropoulos, Nicholas Francis; Nairismägi, Maarja-Liisa; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Hong, Huangming; Kim, Seok Jin; Cho, Junhun; Tse, Eric; Mow, Benjamin; Cai, Qi-Chun; Poon, Li-Mei; Cai, Qing-Qing; Tan, Jing; Chan, Jason Yongsheng; Lim, Johnathan Xiande; Goh, Yeow Tee; Phipps, Colin; Rötzschke, Olaf; Cheng, Chee Leong; Ha, Jeslin Chian Hung; Khoo, Lay Poh; Loh, Yvonne Su Ming; Au-Yeung, Rex; Chan, Thomas Sau-Yan; Kwong, Yok-Lam; Hwang, William; Kim, Won Seog; Bei, Jin-Xin; Lin, Tongyu; Ong, Choon Kiat; Lim, Soon Thye.
  • Lim JQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang D; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Tang T; ONCO-ACP, Duke-NUS Medical School, Singapore, Singapore.
  • Tan D; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Laurensia Y; ONCO-ACP, Duke-NUS Medical School, Singapore, Singapore.
  • Peng RJ; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Wong EKY; Raffles Cancer Centre, Raffles Hospital, Singapore, Singapore.
  • Cheah DMZ; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Chia BKH; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Iqbal J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Grigoropoulos NF; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Nairismägi ML; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Ng CCY; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Rajasegaran V; Department of Pathology, Singapore General Hospital, Academia, Singapore.
  • Hong H; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Kim SJ; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Cho J; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre, Singapore, Singapore.
  • Tse E; Division of Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Mow B; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre, Singapore, Singapore.
  • Cai QC; Division of Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Poon LM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cai QQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Tan J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Chan JY; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Lim JX; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong.
  • Goh YT; Mount Elizabeth Medical Centre, Singapore, Singapore.
  • Phipps C; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Rötzschke O; Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore, Singapore.
  • Cheng CL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Ha JCH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Khoo LP; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Loh YSM; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre, Singapore, Singapore.
  • Au-Yeung R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Chan TS; Department of Pathology, Singapore General Hospital, Academia, Singapore.
  • Kwong YL; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Hwang W; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Kim WS; Singapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Singapore, Singapore.
  • Bei JX; Department of Pathology, Singapore General Hospital, Academia, Singapore.
  • Lin T; Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Ong CK; Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Lim ST; Raffles Cancer Centre, Raffles Hospital, Singapore, Singapore.
Leukemia ; 35(4): 1225, 2021 Apr.
Article en En | MEDLINE | ID: mdl-33686199